OC: Ovarian Cancer
Showing 1 - 25 of >10,000
Ovarian Cancer, Oligometastatic Disease, Recurrent Ovary Cancer Trial (Stereotactic body radiotherapy)
Recruiting
- Ovarian Neoplasms
- +2 more
- Stereotactic body radiotherapy
-
Campobasso, CB, Italy
- +7 more
Sep 23, 2022
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L/Montanide ISA 51 VG, Ampligen,
Terminated
- Ovarian Cancer
- +2 more
- OC-L/Montanide ISA 51 VG
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 18, 2021
Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)
Not yet recruiting
- Ovarian Carcinoma
- PEP-DC1
- +3 more
- (no location specified)
Jan 26, 2023
Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer Trial in France (OSE2101, Pembrolizumab 25 MG/ML [Keytruda])
Recruiting
- Platinum-sensitive Ovarian Cancer
- Relapsed Ovarian Cancer
- OSE2101
- Pembrolizumab 25 MG/ML [Keytruda]
-
Angers, France
- +27 more
Jul 25, 2022
The Immune Landscape of Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- Collection of tumor samples, blood and vaginal and rectal swabs
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland
Aug 2, 2023
PRO for Fighting FT in Ovarian Cancer
Not yet recruiting
- Ovarian Cancer
- Questionnaires
-
Naples, ItalyNation Cancer Institute of Naples, Division of Medical Oncology
Sep 13, 2023
Ovarian Cancer Trial in Roma (Blood samples)
Not yet recruiting
- Ovarian Cancer
- Blood samples
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 3, 2023
Ovarian Cysts, Ovarian Cancer, Ovarian Tumors Trial (Detailed symptomregistration)
Recruiting
- Ovarian Cysts
- +3 more
- Detailed symptomregistration
-
Copenhagen, DenmarkClaus Kim Høgdall
Oct 25, 2022
Ovarian Cancer Trial in Helsinki (Biomolecular profiling)
Recruiting
- Ovarian Cancer
- Biomolecular profiling
-
Helsinki, FinlandHelsinki University and Helsinki University Hospital
Nov 1, 2023
Transforming Ovarian Cancer Diagnostic Pathways
Not yet recruiting
- Ovarian Cancer
-
Birmingham, United Kingdom
- +2 more
Nov 10, 2023
es in OVArian Cancer HRD+ Status in Russian Federation
Recruiting
- Ovarian Cancer
-
Arkhangelsk, Russian Federation
- +18 more
Jun 26, 2023
Ovarian Cancer Trial in Rome (Tumor biopsy)
Recruiting
- Ovarian Cancer
- Tumor biopsy
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 2, 2023
Ovarian Cancer Trial in Roma (Blood sample)
Recruiting
- Ovarian Cancer
- Blood sample
-
Roma, ItalyPoliclinico Universitario Agostino Gemelli
Oct 10, 2023
Ovarian Cancer Trial in Rome (Tumor and blood sample)
Recruiting
- Ovarian Cancer
- Tumor and blood sample
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jul 18, 2023
Removal of Ovaries/Fallopian Tubes and CA-125 Screening to
Completed
- Breast Cancer
- Ovarian Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 28, 2022
Advanced Epithelial Ovarian Cancer Trial in Cairo (Carboplatin/paclitaxel)
Completed
- Advanced Epithelial Ovarian Cancer
-
Cairo, EgyptPharmacology and toxicology department, Faculty of Pharmacy, Cai
Jul 19, 2023
Endocrine Disruptors and Life STILe in Breast Cancer Development
Recruiting
- Breast Cancer
- +5 more
-
Roma, ItalyAlessandra Fabi
Feb 25, 2023
Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma Trial in Houston (TROP2-CAR-NK, Cyclophosphamide, Fludarabine)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- TROP2-CAR-NK
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 27, 2023
Ovarian Cancer Trial in Chongqing (no intervention)
Recruiting
- Ovarian Cancer
- no intervention
-
Chongqing, Chongqing, ChinaChongqing Cancer Hospital
Apr 24, 2022
Ovarian Tumors, Ovarian Diseases Trial (Adebrelimab, Fuzuloparib)
Not yet recruiting
- Ovarian Neoplasms
- Ovarian Diseases
- (no location specified)
Feb 23, 2023
Ovarian Cancer Trial in Rochester (Exercise - Physical Activity, Resiliency Training, Protein Supplementation)
Recruiting
- Ovarian Cancer
- Exercise - Physical Activity
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jul 15, 2022
Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Ovarian Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 26, 2023